Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-079-8 | CAS number: 75147-23-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29.01-19.02.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage (July, 2015)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MatTek Corporation Protocol: EpiOcular TM Eye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals; for use with MatTek Corporation's Reconstructed Human EpiOcular TM Model; 14 July 2014
- Deviations:
- no
- Principles of method if other than guideline:
- The EpiOcular Eye Irritation Test (EIT) was validated by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) and cosmetics Europe between 2008 and 2013. The test consists of a topical exposure of the neat test item to human reconstructed cornea model followed by a cell viability test. Cell viability is measured by dehydrogenase conversion of MTT (3-4,5-dimethyl thiazole 2-yl)2,5-diphenyl-tetrazoliumbromide), present in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. Reduction of cell viability in comparison to untreated negative controls is used to predict eye irritation potential.
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 1,5-dimethylbicyclo[3.2.1]octan-8-one oxime
- EC Number:
- 278-079-8
- EC Name:
- 1,5-dimethylbicyclo[3.2.1]octan-8-one oxime
- Cas Number:
- 75147-23-8
- Molecular formula:
- C10H17NO
- IUPAC Name:
- N-[(8E)-1,5-dimethylbicyclo[3.2.1]octan-8-ylidene]hydroxylamine
Constituent 1
Test animals / tissue source
- Species:
- human
- Strain:
- other: epidermal keratinocytes
- Details on test animals or tissues and environmental conditions:
- CELL CULTURE
- Source: MatTek Corporation (Ashland, MA 01721, USA)
- Model: human-derived epidermal keratinocytes forming a stratified squamous epithelium similar to that found in the human cornea. It consists of highly organized basal cells which progressively flatten out as the apical surface of the tissue is approached, analogous to the normal in vivo corneal epithelium.
- Surface: 0.6 cm2
- Storage conditions: 2 - 8 °C on medium-supplemented agarose gels
IN-LIFE DATES: From: 16.02.2016
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg
- Concentration (if solution): 100 % - Duration of treatment / exposure:
- 6 hours
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- Ca. 18 hours
- Number of animals or in vitro replicates:
- duplicate
- Details on study design:
- PRE-TEST
1) Assessment of direct test Item reduction by MTT
- 50 mg of test item were added to 1 mL of a 1.0 mg/mL MTT solution in DMEM in a 6-well plate.
- Incubation temperature: 37°C +/- 1.5 °C
- Incubation duration: approx. 3 h
- Assessment: blue/purple coloration of the MTT solution indicates chemical interference of the test chemical with MTT reduction.
2) Assessment of colored or staining materials
- 50 mg of test item were added to 1.0 mL of water and to 2 mL of isopropanol in 6-well plates.
- Incubation temperature water mixture: 37 +/- 1.5°C
- Incubation time water mixture: at least 1h
- Incubation temperature isopropanol mixture: room temperature
- Incubation time isopropanol mixture: 2-3 hours
- Assessment: coloration of the test mixtures indicates possible interation of the MTT measurement.
TEST KIT INFORMATION
- EpiOcular and MTT-100 kits are purchased from MatTek Corporation (Ashland, MA 01721, USA)
- Test Kit Lot No: 21597
EXPERIMENTAL DESIGN
- Incubation: overnight at standard culture conditions for 30 minutes.
- Exposure conditions: standard culture conditions (37 ± 1.5 °C, 5 ± 0.5% CO2, 95% RH)
- Removal test item: extensively rinsing with Ca++Mg++-free DPBS
- Post- soak immersion: incubation in assay medium was intended to remove any test item or control absorbed into the tissue.
- Post-treatment: blotting on absorbent material and incubation for 18 hours in assay medium at standard culture conditions.
CONTROLS
- Negative: deionised water
- Positive: methyl acetate
MTT
- Concentration solution: 1.0 mg/mL in DMEM
- Assessment of Direct Test Item Reduction by MTT: 3h incubated in the dark at 37 ± 1.5 °C in a humidified atmosphere of 5 ± 0.5% CO2 in air
- Assessment of Colored or Staining Materials: 1h incubated in the dark at 37 ± 1.5 °C in a humidified atmosphere of 5 ± 0.5% CO2 in air
- Assay: incubation for 180 ± 10 minutes at standard culture conditions and rinsed 3x with DPBS afterwards.
DATA EVALUATION
1) Mean OD value of the blank control wells (ODBlk) for each experiment was calculated.
2) Mean ODBlk from each OD value of the same experiment (blank corrected values) was subtracted.
3) Mean value of 2 aliquots for each tissue (= corrected test item OD) was calculated.
4) Mean value of 2 relating tissues for each control and test item (= corrected mean OD) was calculated. For further calculations only the corrected mean negative control OD value was needed.
5) The corrected OD value of the negative control corresponds to 100% viability. Corrected negative control OD = Negative Control OD - ODBlk = 100% Viability
CALCULATIONS
1) % viability of the 2 relating tissues for each control and test item relative to the negative control (100% control) was calculated.
Viability [%]= 100 x (corrected test item OD / corrected mean negative control OD)
2) The difference of the viability between duplicate tissues Is calculated.
3) The mean test item viability (TI viability) was calculated and the test item is classified according to the prediction model.
VALIDITY CRITERIA
The results are acceptable according to MatTek Protocol, if:
1) The negative control OD is > 0.8 and < 2.5,
2) The mean relative viability of the positive control is below 50% of the negative control viability.
3) The difference of viability between the two relating tissues of a single test item is < 20% in the same run (for positive and negative control tissues and tissues of test items). This applies also to the killed controls (items and negative killed control) and the colorant controls which are calculated as percent values related to the viability of the relating negative control.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: Cell viability (%)
- Run / experiment:
- Mean of all runs
- Value:
- 82.9
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- The mean absorbance of the 2 tissues exposed to the test item was 1.292. From this the relative absorbance value is calculated and this corresponds to the cell viability. For the test item the cell viability was calculated to be 82%, when the negative control was set to 100 %. The threshold for irritancy is ≤ 60%, consequently the test item was not irritant to eye.
Any other information on results incl. tables
Colour change pre-experiments: No change in color was observed.
Pre-experiment assessing direct reduction of MTT by the test chemical: No color changes observed; the test substance did not cause direct reduction of MTT.
Results after treatment for 6 hours with test item and the controls:
Dose group | Mean Absorbance* Tissue 1 and 2 |
Mean Absorbance* of 2 tissues |
Rel. Absorbance (%) Tissue 1 and 2** | Absolute value of the difference of the Rel. Absorbance (%) Tissue 1 and 2 |
Rel. Absorbance (% of Negative Control)** |
Negative Control |
1.545 | 1.558 | 99.2 | 1.6 | 100.0 |
1.610 | 100.8 | ||||
Positive Control |
0.635 | 0.612 | 40.8 | 2.9 | 39.3 |
0.637 | 37.8 | ||||
Test Item | 1.197 | 1.292 | 76.9 | 12.2 | 82.9 |
1.425 | 89.0 |
*Mean of two replicates wells after blank correction
** Relative absorbance (rounded values): 100 * (absorbance (test item/positive control)) / (absorbance negative control)
Validity criteria:
- The negative control OD is > 0.8 and < 2.5 ( 1.564 and 1.612)
- The mean relative viability of the of the positive control is below 50% of the negative control viability (39.3%).
- The difference of viability between the two relating tissues of a single item is < 20% in the same run (value between 1.6 % to 12.2%).
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The test item does not possess eye irritating potential under the test conditions set in an in vitro OECD 492 study.
- Executive summary:
In the current study the eye irritation potential of the test item was assessed in an in vitro study according to OECD 492 guideline, MatTek Corporation Protocol EpiOcular Eye Irritation Test and under GLP. The EpiOcular EIT can be used to identify chemicals that do not require classification for eye irritation or serious eye damage according to the UN GHS classification system. Consequently, a negative result in this test can also be used to conclude that no classification for Eye damage Cat 1 or Eye Irritation Cat 2 is required under CLP. However, a positive result in this test does not allow to differentiate between Eye damage Cat 1 and Eye Irritation Cat 2.
In this in vitro test, the test chemical was topically applied to a 3 -dimensional reconstructed human cornea-like eipithelium (RhCE ) tissue. The tissue viability was measured following exposure and a post-treatment incubation period. The RhCE tissue viability is measured as the degree of enzymatic conversion of the vital dye MTT by the viable cells to the corresponding blue MTT formazan salt, which is quantitatied after extraction from the tissue. The test item, positive and negative controls were tested in duplicate. The exposure duration was 6 hours.
A pre-test is performed to ensure that the colour of the test chemical does not interfere with the MTT formazan measurement (optical interference), and that test chemical does not cause chemical (non-enzymatic) reduction of MTT into MTT formazan (chemical interference).
In the pre-tests, buccoxime did not cause optical nor chemical interference.
In the main study, the cell viability was calculated to be 82%, when the negative control was set to 100 %. The threshold for irritancy is ≤ 60%. Treatment with the positive control induced a decrease in the mean relative absorbance compared with the negative control to 39.3%. The validity criteria of the study were met.
In conclusion, the test item was found to be not irritant to the eye under the experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.